Nedaplatin concurrent with three-dimensional conformal radiotherapy for treatment of locally advanced esophageal carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 48

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

338

HTML

2656

Figures (1-1)

211

Tables (1-4)

189

Sum=3394

Publishing Process of This Article

Item

Count

Browse

950

Download

917

Sum=1867

Dec 28, 2013 (publication date) through Nov 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 28, 2013; 19(48): 9447-9452
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9447

Figure 1 Survival curves for the two groups. NDP: Nedaplatin; DDP: Cisplatin.

Citation: Shen ZT, Wu XH, Li B, Shen JS, Wang Z, Li J, Zhu XX. Nedaplatin concurrent with three-dimensional conformal radiotherapy for treatment of locally advanced esophageal carcinoma. World J Gastroenterol 2013; 19(48): 9447-9452
URL: https://www.wjgnet.com/1007-9327/full/v19/i48/9447.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i48.9447